A new multi-omics resource tool – including genome, transcriptome, proteome, and metabolome data – is now available to help guide future research and drug development in AD.
The AD Atlas (a beta version is available at adatlas.org) is a collaborative effort involving researchers from countries including Germany, USA, Australia, and Qatar. They developed a user-friendly network-based framework for the atlas, to allow easier large-scale cross-omics analyses.
¿Quiere leer más?
Inicie sesión o regístrese para acceder a todo el contenido de Neurodiem.
¿Ya tiene una cuenta? Inicie sesión
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.